| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10K | +0.0% | -92.3% |
| Cost of Revenue | $510K | +30.5% | -55.4% |
| Gross Profit | $789K | -21.7% | -61.0% |
| R&D Expense | $894K | -8.1% | +35.6% |
| SG&A Expense | $844K | -13.8% | -0.2% |
| Operating Income | -$1.3M | +5.6% | — |
| Net Income | -$1.2M | -18.6% | -4837.1% |
| EPS (Basic) | -$0.06 | -20.0% | — |
| EPS (Diluted) | -$0.06 | -20.0% | — |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.3M | -39.9% | -60.4% |
| Accounts Receivable | $562K | -14.5% | -59.6% |
| Current Assets | $4.9M | -33.1% | -54.8% |
| Total Assets | $16.0M | -12.7% | -28.0% |
| Current Liabilities | $720K | -67.2% | -83.2% |
| Total Liabilities | $769K |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.0M | -57.3% | — |
| Capital Expenditures | $16K | +100.3% | — |
| Investing Cash Flow | -$1.5M | — | — |
| Financing Cash Flow | $56K | +98.6% | — |
| Free Cash Flow | -$2.0M | -57.6% | — |
| -82.3% |
| Stockholders' Equity | $15.3M | -5.6% | -14.9% |